7 articles
-
Understanding the role of RUNX1 in ER-positive breast cancer
Dr Karen Blyth is studying why RUNX1 protects against...
-
Developing an Electronic-intervention to help people with breast cancer persist with and adhere to anti-hormone therapy (E-PATH)
People with ER positive breast cancer can be prescribed anti-hormone treatment...
-
Understanding the role of mid-sized non-coding RNAs in ER-positive breast cancer
Dr Anna Git will be studying the role of molecules called mid-sized non-coding RNAs, which she believes could have...
-
Finding the best way to deliver cognitive behavioural therapy to reduce the impact of hot flushes and night sweats
Hot flushes and night sweats are side-effects of breast cancer treatments that can have a huge impact on a woman’s...
-
Predicting a patient’s response to anti-hormone therapy
Patients with hormone-positive breast cancer are usually treated with anti-hormone therapies such as...
-
Endocrinology team
The Endocrinology team aims to understand how and why some patients’ cancers are resistant and others aren't.
-
Investigating new ways to identify patients likely to develop drug resistance
People with certain aggressive types of breast cancer, such as triple negative, have limited treatment options. In...